uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Serum leptin, C-reactive protein, and cancer mortality in the NHANES III
Kings Coll London, Sch Med, Div Canc Studies, Canc Epidemiol Grp, London SE1 9RT, England..
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Endocrine Surgery.
Kings Coll London, Sch Med, Richard Dimbleby Dept Canc Res, Randall Div, London SE1 9RT, England.;Kings Coll London, Sch Med, Richard Dimbleby Dept Canc Res, Div Canc Studies, London SE1 9RT, England..
Univ Zurich, Epidemiol Biostat & Prevent Inst, Div Chron Dis Epidemiol, Zurich, Switzerland..
Show others and affiliations
2016 (English)In: Cancer Medicine, ISSN 2045-7634, E-ISSN 2045-7634, Vol. 5, no 1, 120-128 p.Article in journal (Refereed) PublishedText
Abstract [en]

Adipokines, such as leptin, may affect cancer through its link with inflammation and obesity. We investigated the association between leptin, C-reactive protein, and risk of cancer death while accounting general and abdominal obesity. From the Third National Health and Examination Survey (NHANES III), we selected 5957 adult men and women with baseline measurements of serum leptin and CRP. Multivariable Cox regression was used to assess leptin and CRP levels (low, moderate, high) in relation to risk of cancer death. Stratification analyses were performed for obesity as defined by body mass index (BMI) and waist circumference. Fine and Gray regression was performed to account for death from cardiovascular disease and other causes as competing events. A total of 385 participants died of cancer during a mean follow-up of 18years. After adjusting for BMI and waist circumference, an inverse association with log-transformed leptin was found for women, with a hazard ratio (HR) of 0.81 (95% confidence interval [CI]: 0.51-1.30) and 0.40 (95% CI: 0.24-0.68) for moderate and high compared to low levels of leptin, respectively; P-trend=0.0007). No association for leptin was observed in men, but higher CRP corresponded to increased risk of dying from cancer (HR: 2.98; 95% CI: 1.57-5.64 for the highest vs. lowest categories of CRP). Similar associations were observed with competing risk analysis also adjusted for BMI and waist circumference. Contrasting associations of serum leptin and CRP with cancer mortality may indicate sex-specific biological or environmental pathways linking obesity and cancer in men and women which warrant mechanistic investigations.

Place, publisher, year, edition, pages
2016. Vol. 5, no 1, 120-128 p.
Keyword [en]
Cancer, C-reactive protein, leptin, mortality, prospective study
National Category
Cancer and Oncology
URN: urn:nbn:se:uu:diva-275561DOI: 10.1002/cam4.570ISI: 000367847300013PubMedID: 26632325OAI: oai:DiVA.org:uu-275561DiVA: diva2:900486
Available from: 2016-02-04 Created: 2016-02-04 Last updated: 2016-02-04Bibliographically approved

Open Access in DiVA

fulltext(179 kB)30 downloads
File information
File name FULLTEXT01.pdfFile size 179 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Holmberg, Lars
By organisation
Endocrine Surgery
In the same journal
Cancer Medicine
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 30 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 117 hits
ReferencesLink to record
Permanent link

Direct link